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Letter to the Editor
Group  B  streptococcus  neonatal  infection  in an
intensive care  unit  in Brazil:  high fatality  and
iomissed opportunities  for  antib
Dear Editor,
Group B Streptococcus (GBS) or Streptococcus agalactiae is the
main  cause of death from early-onset neonatal sepsis. Because
of  its fulminant clinical presentation, even with the timely use
of antibiotics and clinical support in the intensive care unit,
the  fatality rate is high and the neonatologist can do little
to  prevent death. In developed countries, such as the United
States,  the incidence of GBS infection reduced from 1.7 cases
per  1000 live births in the early 1990s to 0.34 cases per 1000
live  births after the implementation of antibiotic prophylaxis
during  labor.1
In Brazil, there is no national recommendation for antibi-
otic  prophylaxis during labor to prevent GBS neonatal
infection. The information about GBS incidence derives from
two  studies published a decade ago and ranged between 0.39
and  1.0 per 1000 live births.2,3 A more  recent study that ana-
lyzed  data from 2007 to 2011 reported a GBS incidence of 0.51
per  1000 live births.4 We describe the cases of GBS infection
among infants admitted to a public neonatal intensive care
unit  (NICU) in Brasilia, during 2012 and 2013. The NICU has 40
beds  and it is a regional reference for very low birth weight
babies  (<1500 g) and neonatal surgery.
We  identiﬁed positive blood cultures for GBS using the
microbiology laboratory database. Blood culture obtained from
each patient was  submitted to an automated continuous
monitoring system for bacterial detection (Bactec ﬂuorescent
series  system® Becton Dickinson Microbiology System). The
Streptococcus  genus was  identiﬁed by Gram stain, colony mor-
phology,  hemolysis, and the catalase test. Then, an automated
panel  of Gram-positive identiﬁcation (MicroScan Walk-Away®
Dade Behring Inc.) was  used to identify Streptococcus agalac-
tiae  species. Patients’ medical records were reviewed using a
standardized form to collect data.
During 2012 and 2013, 12,585 babies were born in our hospi-
tal  and eight cases of GBS infection were identiﬁed. All positive
cultures  were  collected during the ﬁrst 48 h of life, representing
early-onset sepsis. Therefore, the incidence of GBS infection
was  0.63 per 1000 live births.tic  prophylaxis
The median gestational age was  33.5 weeks (range 24–41).
The  median number of prenatal consultations was  four (range
3–9).  Not a single pregnant woman had a vaginal-rectal swab
collected  for screening of GBS colonization and none received
antibiotic prophylaxis during labor. Apart from preterm labor,
three  women presented risk factors for early-onset sepsis:
urinary  tract infection at the moment of labor or rupture of
membranes  longer than 18 h. Labor was  vaginal in ﬁve cases
(62.5%)  and a cesarean section in three cases (37.5%).
The median birth weight was  2291 g (range 565–3800), the
median  APGAR score was  seven in the ﬁrst minute and eight
in  the ﬁfth minute. Six newborns were male (75%) and two
female  (25%). No newborn had any recognizable birth defect.
All  presented symptoms of respiratory distress and sepsis, two
just after birth and the others during the ﬁrst 24 h of life. All
infants  received ampicillin plus gentamicin. Five infants died,
a  case-fatality rate of 62.5%. A summary of cases is presented
in  Table 1
The  GBS incidence and the high fatality rate are in line with
other  Brazilian studies,2–4 but higher than that achieved with
antibiotic  prophylaxis during labor, according to GBS prenatal
screening  in developed countries.1
Although the number of prenatal consultations was  not
low,  not a single woman had been screened for GBS colo-
nization  through vaginal-rectal swab. Additionally, there were
missed opportunities for antibiotic prophylaxis according to
the latest Centers for Disease Control and Prevention (CDC)
recommendations.1 Antibiotic prophylaxis is recommended
to  every preterm labor with unknown status of GBS coloniza-
tion,  as it was  the case with four (50%) of our cases (excluding
one  case of a preterm infant that was  born through cesarean
delivery due to gestational hypertension without labor onset).
However,  none has received antibiotic during labor. A previous
study  in Brazil, had already reported 57% of inappropriate use
of  antibiotic prophylaxis during labor.5
In conclusion, GBS remains an important cause of early
mortality among Brazilian neonates. Well-established guide-
lines  for its prevention have been applied in developed
countries for more  than a decade. Nevertheless, the lack of
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Table 1 – Data from 8 infants with Streptococcus agalactiae infection, Brasília, 2012–2013.
Cases
1 2 3 4 5 6 7 8
Date of birth 06/01/12 21/03/12 11/08/12 20/10/12 27/05/13 11/06/13 06/07/13 03/09/13
Number of prenatal consultations 4 9 4 4 9 3 4 3
Type of labor Cesarean Vaginal Vaginal Vaginal Cesarean Cesarean Vaginal Vaginal
Gestational age (weeks) 30 38 32 24 38 26 35 41
Birth weight (g) 1232 3475 1830 565 3800 860 2751 3200
Sex Male Male Female Female Male Male Male Male
APGAR score 1/5 min 7/8 8/9 8/9 6/7 5/8 7/7 8/9 1/7
Duration of membranes rupture At labor At labor 6 days 7 days 12 h At labor At labor 5 h
Time of symptom onset 14 h 8 h At birth At birth 12 h 24 h 12 h 12 h
 birth
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5Time of antibiotic prescription 42 h 12 h At
Time of death 66 h Survived Su
renatal screening and missed opportunities for antibiotic
rophylaxis seem to be frequent in Brazil. Implementa-
ion of evidence-based practices is necessary in Brazil to
educe  the burden of GBS and prevent death among healthy
eonates.
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